Treating muscular dystrophy by stimulating intrinsic repair.

about

Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength.Muscle stem cells at a glance Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia.Cellular dynamics in the muscle satellite cell niche.

P2860

Q30576111-1B4080A8-42D9-40E0-B12E-2332C83090AF Q34433427-71A78D83-A66B-4E95-8D46-C029F5BCE647 Q35616824-2C7995A1-EDCA-493A-B2DA-8B4E6C1150ED Q37361381-A2594C43-1AAB-4608-A9E7-ADACFC29957D

P2860

Treating muscular dystrophy by stimulating intrinsic repair.

Item

http://www.wikidata.org/entity/Q46403550

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Treating muscular dystrophy by stimulating intrinsic repair.

@en

Treating muscular dystrophy by stimulating intrinsic repair.

@nl

type

Item

label

Treating muscular dystrophy by stimulating intrinsic repair.

@en

Treating muscular dystrophy by stimulating intrinsic repair.

@nl

prefLabel

Treating muscular dystrophy by stimulating intrinsic repair.

@en

Treating muscular dystrophy by stimulating intrinsic repair.

@nl

P1476

Treating muscular dystrophy by stimulating intrinsic repair.

@en

P2093

C Florian Bentzinger

http://www.w3.org/2001/XMLSchema#string

Michael A Rudnicki

http://www.w3.org/2001/XMLSchema#string

Yu Xin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency

Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse

Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy

Building muscle: molecular regulation of myogenesis.

The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell.

Wnt7a treatment ameliorates muscular dystrophy.

The emerging biology of muscle stem cells: implications for cell-based therapies.

Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy.

P304

237-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/RME.13.27

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236579638

http://www.w3.org/2001/XMLSchema#string

P698

23627818

http://www.w3.org/2001/XMLSchema#string

Treating muscular dystrophy by stimulating intrinsic repair.

about

P2860

P2860

Treating muscular dystrophy by stimulating intrinsic repair.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698